Literature DB >> 8738227

Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage.

J E Barker1, S J Heales, A Cassidy, J P Bolaños, J M Land, J B Clark.   

Abstract

Loss of the intracellular antioxidant glutathione (GSH) from the substantia nigra is considered to be an early event in the pathogenesis of Parkinson's disease (PD). While the cause of the loss is unclear, an imbalance in the enzymes associated with the synthesis, utilisation, degradation and translocation of GSH has been implicated. The enzyme glutathione reductase is also important in GSH homeostasis: it regenerates GSH from the oxidised from (GSSG). However, to date the activity and regulation of glutathione reductase in conditions such as PD have not been explored. In view of this we have measured the effects of GSH depletion on glutathione reductase activity of the rat brain. Other glutathione related enzymes were also measured. Using pre-weanling rats, brain GSH was depleted by up to 60% by subcutaneous administration of L-buthionine sulfoximine. The only enzyme affected by GSH depletion was glutathione reductase; its activity being reduced by approximately 40%. As GSH inactivates a number of oxidising species including peroxynitrite (ONOO-), we additionally investigated the susceptibility of glutathione reductase to ONOO- in vitro, using purified enzyme. ONOO- decreased glutathione reductase activity in a concentration dependent manner with an apparent 50% inhibition occurring at an initial concentration of 0.09 mM. These data suggest that GSH is important in the maintenance glutathione reductase activity. This may arise in part from its ability to inactivate oxidising agents such as ONOO-.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738227     DOI: 10.1016/0006-8993(96)00003-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine.

Authors:  Amit Kamboj; Ravi Kiran; Rajat Sandhir
Journal:  Exp Brain Res       Date:  2005-11-24       Impact factor: 1.972

4.  Disruption of the integrity and function of brain microvascular endothelial cells in culture by exposure to diesel engine exhaust particles.

Authors:  Shakila Tobwala; Xinsheng Zhang; Youyou Zheng; Hsiu-Jen Wang; William A Banks; Nuran Ercal
Journal:  Toxicol Lett       Date:  2013-03-28       Impact factor: 4.372

5.  Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia.

Authors:  Andrew Campbell; Jared Bushman; Joshua Munger; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

6.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.

Authors:  A R White; S J Collins; F Maher; M F Jobling; L R Stewart; J M Thyer; K Beyreuther; C L Masters; R Cappai
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.

Authors:  Donna W Lee; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Julie K Andersen
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 8.  Redox imbalance in Parkinson's disease.

Authors:  Shankar J Chinta; Julie K Andersen
Journal:  Biochim Biophys Acta       Date:  2008-03-04

9.  Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.

Authors:  Harikesh Kalonia; Puneet Kumar; Anil Kumar; Bimla Nehru
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

10.  Role of astrocytes in pathogenesis of ischemic brain injury.

Authors:  B Gabryel; H I Trzeciak
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.